References
- Campbell, C. L., Smyth, S., Montalescot, G. and Steinhubl, S. R. : Aspirin dose for the prevention of cardiovascular disease. JAMA 297, 2018 (2007). https://doi.org/10.1001/jama.297.18.2018
- Bartolucci, A. A., Tendera, M. and Howard, G. : Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am. J. Cardiol. 107, 1796 (2011). https://doi.org/10.1016/j.amjcard.2011.02.325
- Vane, J. R. and Botting, R. M. : Mechanism of action of nonsteroidal anti-inflammatory drugs. The American Journal of Medicine 104, 2S (1998).
- Imaeda, A. B., Watanabe, A., Sohail, M. A., Mahmood, S., Mohamadnejad, M., Sutterwala, F. S., Flavell, R. A. and Mehal, W. Z. : Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119, 305 (2009).
- Glaser, K. B. : Cyclooxygenase selectivity and NSAIDs: cyclooxygeanse-2 selectivity of etodolac. Inflamopharmacology 3, 335 (1995). https://doi.org/10.1007/BF02668029
- Teoh, N. C. and Farrell, G. C. : Hepatotoxicity associated with non-steroidal anti-inflammtory drugs. Clin Liver Dis. 7, 401 (2003). https://doi.org/10.1016/S1089-3261(03)00022-9
- Vane, J. R. and Botting, R. M. : Mechanism of action of antiinflammatory drugs. Scand J. Rheumatology 102, 9 (1996).
- Charles, F. L., Lora, L. A., Morton, P. G. and Leonard, L. L. : Drug information handbook. 19th ed. Ohio: Lexi-CompInc. (2010).
- Marmura, M. J., Hopkins, M., Andrel, J., Young, W. B., Biondi, D. M., Rupnow, M. F. and Armstrong, R. B. : Electronic medical records as a research tool: Evaluating topiramate use at a headache center. Headache 50, 769 (2010). https://doi.org/10.1111/j.1526-4610.2010.01624.x
- Elizabeth, H. H. : Elevated liver function tests in type 2 diabetes. Clinical Diabetes 23, 115 (2005). https://doi.org/10.2337/diaclin.23.3.115
- Koda-kimble, M. A., Young, L. Y., Alldredge, B. K., Corelli, R. B., Guglielmo, B. J., Kradjan, W. A. and Williams, B. R. : Applied therapeutics-The clinical use of drugs (9th Ed). Baltimore, Philadelphia: Lippincott Williams&Wilkins (2009).
- Mary, L. : Basic skills in interpreting laboratory test, 4th ed. (2009).
- Banichou, C., Dana, G. and Flahault, A. : Causality assessment of adverse reactions to drug-II. An original model for validation of drug causality assessment methods: case reports with positiverechallenge. J. Clin. Epidemol. 4, 1331 (1993).
- Dana, G. and Benichou, C. : Causality assessment of adverse reactions to drugs- I.A novel method based on the conclusions of international consensus meetings:application to druginduced liver injuries. J. Clin. Epidemol. 46, 1323 (1993). https://doi.org/10.1016/0895-4356(93)90101-6
- Liss, G., Rattan, S. and Lewis, J. H. : Predicting and preventing actue drug-induced liver injury; what's new in 2010? Expert. Opin. Drug Metab. Toxicol. 6, 1047 (2010). https://doi.org/10.1517/17425255.2010.503706
- Stine, J. G. and Lewis, J. H. : Drug-induced liver injury: a summary of recent advances. Expert. Opin. Drug Metab. Toxicol. 7, 875 (2011). https://doi.org/10.1517/17425255.2011.577415
- Nachimuthu, S., Volfinzon, L. and Gopal, L. : Acute hepatocellular and cholestatic injury in a patient taking celecoxib. Postgrad Med. J. 7, 548 (2001).
- Watkins, P. B. : Biomarkers for the diagnosis and management of drug-induced liver injury. Semin Liver Dis. 24, 393 (2009).
- Treeprasertsuk, S., Huntrakul, J., Ridtitid, W., Kullavanijata, P. and Bjornsson, E. : The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents. Alimentary Pharmacol. Ther. 31, 1200 (2010). https://doi.org/10.1111/j.1365-2036.2010.04292.x
- Zimmerman, H. J. : The spectrum of hepatootxicity. PerspectBiol. Med. 12, 135 (1968).
- O'Connor, N., Dargan, P. I. and Jones, A. L. : Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM 96, 787 (2003). https://doi.org/10.1093/qjmed/hcg138
- Bessone, F. : Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage. WJG 16, 5651 (2010). https://doi.org/10.3748/wjg.v16.i45.5651
- Agundez, J. A., Lucena, M. I., Martinez, C., Andrade, R. J., Blanca, M., Ayuso, P. and Garcia-Martin, E. : Assessment of nonsteroidal anti-inflammatory drug-indcued hepatotoxicity. Expert. Opin. Drug Metab. Toxicol. 7, 817 (2011). https://doi.org/10.1517/17425255.2011.574613
- Tolman, K. G. : Hepatotoxicity of Non-Narcotic Anagesics. Am. J. Med. 105, 13S (1998). https://doi.org/10.1016/S0002-9343(98)00070-9
- Elzouki, A. N. and Lindgren, S. : Granulomatous hepatitis induced by aspirin-kodein analgesics. J. Intern. Med. 239, 279 (1996). https://doi.org/10.1046/j.1365-2796.1996.408761000.x
- Laine, L., White, W. B., Rostom, A. and Hochberg, M. : COX- 2 selective inhibitors in the treatment of osteoarthritis. Semin Arthritis Rheum 38, 165 (2008). https://doi.org/10.1016/j.semarthrit.2007.10.004
- Travers, F. L. and Hughes, G. R. : Salicylate hepatotoxicity in systemic lupus erythematosus: a common occurrence? Br. Med. J. 2, 1532 (1978).
- Kuffner, E. K., Dart, R. C., Bogdan, G. M., Hill, R. E., Casper, E. and Darton, L. : Effect of maximal daily doses of acetaminophen on the liver of alcohol patients. Arch. Intern. Med. 161, 2245 (2001).
- Haviv, Y. S. : Low-dose paracetamol probably associated with hepatic injury in a patients with chronic renal failure. Clin. Drug. Invest. 19, 389 (2000). https://doi.org/10.2165/00044011-200019050-00010
- Boelsterli, U. A. : Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug. Saf. 25, 633 (2002). https://doi.org/10.2165/00002018-200225090-00003
- Ackerman, Z., Flugelman, M. Y., Wax, Y., Shouval, D. and Levy, M. : Hepatitis during measles in young adults: possible role of antipyretic drugs? Hepatology 10, 203 (1989). https://doi.org/10.1002/hep.1840100214
- Alam, I., Ferrell, L. D. and Bass, N. M. : Vanishing bile duct syndrome temporally associated with ibuprofen use. Am. J. Gastroenterol. 91, 1626 (1996).
- Benson, G. D. : Hepatotoxicity following the therapeutic use of antipyretic analgesics. Am. J. Med. 75, 85 (1983).
- Goldkind, L. and Laine, L. : A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. Pharmacoepidemiol. Drug. Saf. 15, 213 (2006).
- Prescott, L. F. : Effects of non-narcotic analgesics on the liver. Drugs 32, 129 (1986). https://doi.org/10.2165/00003495-198600324-00010
- Masubuchi, Y., Saito, H. and Horie, T. : Sturctural Requirements for the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs in isolated rat hepatocytes. J. Pharmacol. Exp. Ther. 287, 208 (1998).
- Mukherjee, D., Nissen, S. E and Topol, E. J. : Risk of Cardiovascular events associated with selective COX-2 inhibitors. JAMA 286, 954 (2001). https://doi.org/10.1001/jama.286.8.954
- Paik, Y. H., Kim, J. K., Lee, J. I., Kang, S. H., Kim, D. Y., An, S. H., Lee, S. J., Lee, D. K., Han, K. H., Chon, C. Y., Lee, S. I., Lee, K. S. and Benner, D. A. : Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats. Gut 58, 1517 (2009). https://doi.org/10.1136/gut.2008.157420
- Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., Burr, A. M., Kent, J. D., Lefkowith, J. B., Verburg, K. M. and Geis, G. S. : Gastrointestinal toxicity with celecoxibvsnonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 284, 1247 (2000). https://doi.org/10.1001/jama.284.10.1247
- Matsumura, T., Suzuki, T., Aizawa, K., Sawaki, D., Munemasa, Y., Ishida, J. and Nagai, R. : Regulation of transforming growh factor-b-dependent cyclooxygenase-2 expression in fibroblasts. Journal of Biological Chemistry 284, 35861 (2009). https://doi.org/10.1074/jbc.M109.014639